U-Chart Analysis:Cyfuse Biomedical K.K.:4892

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Cyfuse Biomedical K.K. 4892 Medicals 東証グロース December 1, 2000 2022.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Cyfuse Biomedical K.K. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Cyfuse Biomedical K.K. Balance Sheet 2023年12月期 Cyfuse Biomedical K.K. Balance Sheet 2022年12月期 Cyfuse Biomedical K.K. Balance Sheet 2021年12月期 Cyfuse Biomedical K.K. Balance Sheet 2020年12月期 Cyfuse Biomedical K.K. Balance Sheet 年0月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents 3,874 4,437 2,413 2,073 -
Other Current AssetsHelp 114 128 146 79 -
Tangible Fixed AssetsHelp 170 189 27 33 -
Intangible Fixed AssetHelp 4 5 5 6 -
Investments and OthersHelp 53 55 56 6 -
Total AssetsHelp 4,215 4,815 2,646 2,196 -
Total Current LiabilitiesHelp 666 683 386 207 -
Total Long-term LiabilitiesHelp 345 363 360 440 -
Shareholder's EquityHelp 3,203 3,770 1,900 1,549 -
Total LiabilitiesHelp 4,215 4,815 2,646 2,196 -

Cyfuse Biomedical K.K. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Cyfuse Biomedical K.K. Profit and Loss Account 2023年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2022年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2021年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 2020年12月期 Cyfuse Biomedical K.K. Profit and Loss Account 年0月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales 61 374 708 137 -
Total Sales 61 374 708 137 -
Cost of SalesHelp 23 133 138 70 -
Other Costs and RevenueHelp 627 715 428 397 -
Total CostsHelp 650 848 565 467 -
Net RevenueHelp 38 241 571 67 -
Earnings Before TaxHelp -586 -472 145 -327 -
Net IncomeHelp -589 -474 143 -330 -
Net Income -589 -474 143 -330 -

Cyfuse Biomedical K.K. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Cyfuse Biomedical K.K. Cash Flow Statement 2023年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2022年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2021年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 2020年12月期 Cyfuse Biomedical K.K. Cash Flow Statement 年0月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help -562 -404 162 -294 -
Investing Cash Flow(ICF)Help -19 -431 -51 -0 -
Financing Cash FlowHelp 18 2,659 229 489 -
Exchange Difference of Cash and Cash EquivalentsHelp 0 0 0 0 -
Net Increase and Decrease in Cash and Cash Equivalentsn -564 1,824 340 195 -

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Cyfuse Biomedical K.K.

Company where related level is highHelp

SAWAI PHARMACEUTICAL CO.,LTD.
DAIICHI SANKYO COMPANY, LIMITED
BrightPath Biotherapeutics Co., Ltd.
Shionogi & Co.,Ltd.
DENKA SEIKEN Co.,Ltd.
Nxera Pharma Co., Ltd.
Daito Pharmaceutical Co.,Ltd.
TSUMURA & CO.
Perseus Proteomics Inc.
Kyowa Kirin Co.,Ltd.